ChemicalBook > CAS DataBase List > Upadacitinib hemihydrate
Upadacitinib hemihydrate
- Product Name
- Upadacitinib hemihydrate
- CAS No.
- 2050057-56-0
- Chemical Name
- Upadacitinib hemihydrate
- Synonyms
- Upadacitinib hemihydrate;ABT494 hemihydrate;ABT 494 hemihydrate;ABT-494 hemihydrate;Upadacitinib Hydrate;Cinchonanium, 1-[13,5-bis(trifluoromethyllphenyllmethyl]-9-hydroxy-1'- [[3-(trifluoromethyl)phenyllmethyl},bromide(1:2), (8a,9R)-";1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, hydrate (2:1), (3S,4R)-
- CBNumber
- CB29872273
- Molecular Formula
- C17H21F3N6O2
- Formula Weight
- 398.39
- MOL File
- 2050057-56-0.mol
More
Less
Upadacitinib hemihydrate Property
- InChI
- InChI=1/C17H19F3N6O.H2O/c1-2-10-7-25(16(27)24-9-17(18,19)20)8-11(10)13-5-22-14-6-23-15-12(26(13)14)3-4-21-15;/h3-6,10-11,21H,2,7-9H2,1H3,(H,24,27);1H2/t10-,11+;/s3
- InChIKey
- VJSRYIXHEWRBKD-NFGOAHBONA-N
- SMILES
- C([C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1C1=CN=C2C=NC3NC=CC=3N12)C.O |&1:1,13,r|
More
Less
Upadacitinib hemihydrate Chemical Properties,Usage,Production
Clinical Use
RINVOQ is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs). RINVOQ may be used as monotherapy or in combination with methotrexate. Each prolonged-release tablet (RINVOQ 15 mg prolonged-release tablets.) contains upadacitinib hemihydrate, equivalent to 15 mg of upadacitinib.